Run these at baseline and post-protocol
Certain profiles warrant more careful monitoring: Patients with existing diabetic retinopathy, particularly those with a history of poor blood sugar control Patients who have been diagnosed with or are at risk for age-related macular degeneration Those with hypertension, high cholesterol, or obstructive sleep apnea Patients with a small cup-to-disc ratio, which can only be assessed during a dilated eye exam Those starting semaglutide specifically, given its stronger association with both NAION and diabetic retinopathy compared to tirzepatide Knowing your individual risk profile before starting therapy, not after a vision change occurs, is the most effective approach
2012;7:e47595
Mechanism Comparison Table How IGF-1 LR3 Differs From GH Secretagogue Research Compounds like the CJC-1295 and Ipamorelin blend work upstream of IGF-1 LR3 in the growth hormone axis they stimulate the pituitary gland to release growth hormone, which then prompts the liver to produce IGF-1 naturally
For individuals managing diabetes or obesity, excessive alcohol intake can worsen blood sugar control and weight management, raising concerns about the safety of drinking while on medications like Semaglutide